BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30795904)

  • 1. Therapeutic erythroapheresis: Experience in patients with polycythemia vera and secondary erythrocytosis.
    Parra Salinas I; Recasens Flores V; Montañés MÁ; García-Erce JA
    Med Clin (Barc); 2020 Jan; 154(1):16-19. PubMed ID: 30795904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis.
    Evers D; Kerkhoffs JL; Van Egmond L; Schipperus MR; Wijermans PW
    J Clin Apher; 2014 Jun; 29(3):133-8. PubMed ID: 24130064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy in relation to blood volume and delta-hematocrit: an evaluation in hereditary hemochromatosis polycythemia vera and secondary erythrocytosis.
    Evers D; Kerkhoffs JL; Van Egmond L; Wijermans PW
    Transfus Apher Sci; 2013 Apr; 48(2):187. PubMed ID: 23809828
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison between erythrocytapheresis and venesection for the treatment of JAK2-mutated polycythaemia.
    Ngo TQ; Scott MW; Sirdesai S; Hempton JL; Hodges GS; Campbell PJ
    Intern Med J; 2024 Jun; 54(6):909-915. PubMed ID: 38145421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advantages of isovolemic large-volume erythrocytapheresis as a rapidly effective and long-lasting treatment modality for red blood cell depletion in patients with polycythemia vera.
    Kaboth U; Rumpf KW; Liersch T; Vehmeyer K; Krieter D; Kaboth W
    Ther Apher; 1997 May; 1(2):131-4. PubMed ID: 10225758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Erythrocytapheresis Is Effective in Treating High Altitude Polycythemia on the Qinghai-Tibet Plateau.
    Dong Y; Dun B; Wang Dui PB; Zhuo Ma LB; Fang J; Yang Zong CR; Ji Z; Xu P; Zheng Y; Yue F; Li J; Li X
    Wilderness Environ Med; 2020 Dec; 31(4):426-430. PubMed ID: 33132033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey on the usage of therapeutic erythrocytapheresis in transfusion services in Italy for the treatment of polycythemia vera, secondary erythrocytosis and hemochromatosis.
    Iuliani O; Passeri C; Inghilleri G; Di Bartolomeo E; Abbruzzese L; Bianco I; Foddai ML; Natale GA; De Fusco G; D'Onofrio M; Fadda MG; Dominijanni A; Savignano C; Ostuni A
    Transfus Apher Sci; 2023 Oct; 62(5):103752. PubMed ID: 37355441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis?
    Teofili L; Valentini CG; Rossi E; De Stefano V
    Leukemia; 2019 Jan; 33(1):279-281. PubMed ID: 30518810
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
    Alvarez-Larrán A; Pérez-Encinas M; Ferrer-Marín F; Hernández-Boluda JC; Ramírez MJ; Martínez-López J; Magro E; Cruz Y; Mata MI; Aragües P; Fox ML; Cuevas B; Montesdeoca S; Hernández-Rivas JA; García-Gutiérrez V; Gómez-Casares MT; Steegmann JL; Durán MA; Gómez M; Kerguelen A; Bárez A; García MC; Boqué C; Raya JM; Martínez C; Albors M; García F; Burgaleta C; Besses C;
    Haematologica; 2017 Jan; 102(1):103-109. PubMed ID: 27686377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia.
    Shih LY; Lee CT; See LC; Ou YC; Dunn P; Wang PN; Kuo MC; Wu JH
    Eur J Clin Invest; 1998 Jul; 28(7):569-76. PubMed ID: 9726038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns.
    Streiff MB; Smith B; Spivak JL
    Blood; 2002 Feb; 99(4):1144-9. PubMed ID: 11830459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erythrocytapheresis in patients with secondary polyglobulia].
    Kessler P
    Vnitr Lek; 2004 Sep; 50(9):682-4. PubMed ID: 15580902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of erythrocytapheresis in secondary erythrocytosis therapy.
    Pollari G; Antonini V; Izzo A; Moreschini G; Serraino M; Tonelli V; D'Angiolino A; Migliaccio M
    Clin Hemorheol Microcirc; 1999; 21(3-4):353-5. PubMed ID: 10711770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of hematocrit control on symptom burden among polycythemia vera patients: Insights from the CYTO-PV and MPN-SAF patient cohorts.
    Scherber RM; Geyer HL; Dueck AC; Kosiorek HE; Finazzi G; Cavazzina R; Masciulli A; Scarano M; Vannucchi AM; Mesa RA; Barbui T
    Leuk Lymphoma; 2017 Jun; 58(6):1481-1487. PubMed ID: 27830999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of arterial compliance in polycythemia vera patients: short and long-term influence of phlebotomy.
    Nemets A; Isakov I; Huerta M; Barshai Y; Oren S; Lugassy G
    Isr Med Assoc J; 2006 Dec; 8(12):845-7. PubMed ID: 17214101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic erythrocytosis: a study of a large cohort with a long follow-up.
    Randi ML; Bertozzi I; Cosi E; Santarossa C; Peroni E; Fabris F
    Ann Hematol; 2016 Jan; 95(2):233-7. PubMed ID: 26547864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of serum VEGF levels in untreated erythrocytosis patients.
    Maktouf C; Bounemra A; Mahjoub S; Msadek F; Khlif A; Karoui M; Hdiji S; Zriba S; Romdhane NB; Elloumi M
    Pathol Biol (Paris); 2011 Aug; 59(4):240-2. PubMed ID: 20674193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis.
    Rusak T; Piszcz J; Misztal T; Brańska-Januszewska J; Tomasiak M
    Thromb Res; 2014 Jul; 134(1):192-8. PubMed ID: 24824295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyanotic congenital heart disease (CCHD) with symptomatic erythrocytosis.
    Rose SS; Shah AA; Hoover DR; Saidi P
    J Gen Intern Med; 2007 Dec; 22(12):1775-7. PubMed ID: 17917783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the impact of serial therapeutic phlebotomy in polycythaemia on laboratory and clinical parameters using a fixed interval and fixed volume protocol.
    Bhatia S; Kaur P; Kaur G; Tahlan A; Saini V; Bedi R; Mittal K; Sood T
    Transfus Clin Biol; 2023 Feb; 30(1):63-68. PubMed ID: 35835318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.